Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 funding notice text was removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about funding lapse and operating status was added, and the footer now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe Record History page now includes a glossary option and color-coded additions and deletions with revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision history shows a new entry for v3.3.4 and removal of v3.3.3, updating the page's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing Revision: v3.3.2 plus removing the HHS Vulnerability Disclosure text, which are minor metadata changes that do not affect study content or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe record history shows a new revision entry v3.3.2 and the older revision v3.3.1 is removed from the listing.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.